HomeCRBP • NASDAQ
add
Corbus Pharmaceuticals Holdings Inc
Previous close
$19.36
Day range
$17.47 - $19.55
Year range
$4.64 - $20.77
Market cap
221.33M USD
Avg Volume
298.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.96M | -3.83% |
Net income | -17.66M | -76.67% |
Net profit margin | — | — |
Earnings per share | -1.44 | -60.00% |
EBITDA | -19.10M | -76.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 116.59M | -20.70% |
Total assets | 125.08M | -17.70% |
Total liabilities | 14.09M | -46.69% |
Total equity | 110.99M | — |
Shares outstanding | 12.26M | — |
Price to book | 2.14 | — |
Return on assets | -36.13% | — |
Return on capital | -39.34% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -17.66M | -76.67% |
Cash from operations | -16.60M | -85.61% |
Cash from investing | 17.74M | 207.93% |
Cash from financing | — | — |
Net change in cash | 1.14M | -88.06% |
Free cash flow | -10.35M | -97.12% |
About
Founded
Jan 1, 2009
Website
Employees
28